Statement Of Income

Fuji Pharma Co.,Ltd. - Filing #7290798

Concept 2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
Statement of income
Statement of income
Net sales
Net sales
41,925,000,000 JPY
46,138,000,000 JPY
37,421,000,000 JPY
40,889,000,000 JPY
Net sales of goods
3,246,000,000 JPY
2,466,000,000 JPY
Net sales of finished goods
38,679,000,000 JPY
34,955,000,000 JPY
Operating revenue
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
162,000,000 JPY
120,000,000 JPY
Welfare expenses
475,000,000 JPY
397,000,000 JPY
Depreciation
946,000,000 JPY
994,000,000 JPY
812,000,000 JPY
825,000,000 JPY
Operating expenses
Cost of sales
Cost of products manufactured
23,194,000,000 JPY
20,954,000,000 JPY
Cost of purchased goods
1,909,000,000 JPY
2,117,000,000 JPY
Cost of sales
25,961,000,000 JPY
28,294,000,000 JPY
22,528,000,000 JPY
24,374,000,000 JPY
Cost of goods sold
Cost of finished goods sold
Selling, general and administrative expenses
12,533,000,000 JPY
13,963,000,000 JPY
11,434,000,000 JPY
12,656,000,000 JPY
Provision of allowance for doubtful accounts
0 JPY
0 JPY
Other
2,505,000,000 JPY
5,241,000,000 JPY
2,193,000,000 JPY
4,698,000,000 JPY
Operating expenses
Other operating expenses
Operating expenses
Research and development expenses
3,401,000,000 JPY
3,401,000,000 JPY
3,184,000,000 JPY
3,184,000,000 JPY
Gross profit (loss)
15,964,000,000 JPY
17,844,000,000 JPY
14,893,000,000 JPY
16,514,000,000 JPY
General and administrative expenses
Salaries
Operating profit (loss)
3,430,000,000 JPY
3,880,000,000 JPY
3,458,000,000 JPY
3,858,000,000 JPY
Gross profit
Ordinary profit (loss)
3,953,000,000 JPY
4,445,000,000 JPY
4,071,000,000 JPY
4,519,000,000 JPY
Non-operating income
Dividend income
JPY
JPY
77,000,000 JPY
77,000,000 JPY
Non-operating income
761,000,000 JPY
812,000,000 JPY
732,000,000 JPY
790,000,000 JPY
Financial revenue
Other
116,000,000 JPY
104,000,000 JPY
116,000,000 JPY
111,000,000 JPY
Non-operating expenses
Interest expenses
188,000,000 JPY
196,000,000 JPY
97,000,000 JPY
107,000,000 JPY
Non-operating expenses
Selling, general and administrative expenses
Entertainment expenses
18,000,000 JPY
12,000,000 JPY
Amortization of goodwill
337,000,000 JPY
316,000,000 JPY
Extraordinary income
3,953,000,000 JPY
3,953,000,000 JPY
JPY
JPY
Non-operating expenses
Non-operating expenses
238,000,000 JPY
247,000,000 JPY
119,000,000 JPY
129,000,000 JPY
Financial expenses
Bond issuance costs
JPY
JPY
14,000,000 JPY
14,000,000 JPY
Other
50,000,000 JPY
50,000,000 JPY
8,000,000 JPY
8,000,000 JPY
Extraordinary losses
123,000,000 JPY
123,000,000 JPY
120,000,000 JPY
120,000,000 JPY
Extraordinary income
Gain on sale of investment securities
3,118,000,000 JPY
3,118,000,000 JPY
JPY
JPY
Profit (loss) before income taxes
7,784,000,000 JPY
8,276,000,000 JPY
3,951,000,000 JPY
4,399,000,000 JPY
Income taxes - current
1,908,000,000 JPY
2,110,000,000 JPY
871,000,000 JPY
1,002,000,000 JPY
Extraordinary losses
Loss on disaster
62,000,000 JPY
62,000,000 JPY
JPY
JPY
Income taxes - deferred
66,000,000 JPY
18,000,000 JPY
-37,000,000 JPY
-38,000,000 JPY
General and administrative expenses
Income taxes
1,975,000,000 JPY
2,128,000,000 JPY
834,000,000 JPY
963,000,000 JPY
Profit (loss)
5,808,000,000 JPY
6,147,000,000 JPY
5,808,000,000 JPY
5,808,000,000 JPY
5,808,000,000 JPY
JPY
JPY
JPY
3,117,000,000 JPY
3,117,000,000 JPY
3,117,000,000 JPY
3,435,000,000 JPY
3,117,000,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.